IPO Grey Market: Legal or Illegal?

Every investor who sees a GMP number eventually asks the same question: if this is not official, is it even allowed? The answer requires a distinction that is easy to miss. The grey market is not an officially recognised market, and it is not regulated by SEBI, but merely reading or publishing a premium is not itself a criminal act. Participating in grey market deals, however, exposes you to risks that regulated markets are designed to eliminate.

Why It Is Called Grey

Markets are usually described in three shades. A white market is regulated and transparent, like the NSE and BSE. A black market deals in goods or transactions that are outright prohibited. A grey market sits in between: transactions that are not banned outright but occur outside the regulated framework, with no legal enforceability and no supervisory oversight.

The IPO grey market falls squarely in the third bucket. It exists because there is genuine demand to take a view on a listing before the listing happens, and no regulated instrument to satisfy it.

What SEBI Says, and Does Not Say

SEBI regulates the issuance process: the prospectus, disclosures, pricing methodology, the ASBA mechanism, allotment rules and listing. It does not recognise, register or supervise grey market transactions. Practically, this means:

• GMP has no official status. You will never see it in a prospectus or an exchange filing.
• Grey market contracts are not enforceable. If a counterparty defaults, there is no arbitration mechanism, no investor protection fund and no exchange guarantee.
• Regulated intermediaries cannot use or advertise GMP as investment advice. A registered adviser recommending an IPO purely on grey market chatter is on very thin ice.
• Publishing observed grey market prices as information, which is what IPO trackers do, is treated as market reporting rather than as an offer to transact.

The Real Risks for Retail Investors

Even if you never place a grey market trade, GMP can hurt you indirectly:

• Anchoring. A large premium anchors your expectations and pushes you to apply to issues you would otherwise skip.
• Leverage. Some investors borrow to apply because the implied gain looks certain. Premiums are not certain, and interest is.
• Manipulation. Thin quoting means a small amount of money can set a headline number that circulates widely. This is most acute in SME issues.
• Counterparty default. For anyone who does transact, there is no recourse whatsoever when a dealer walks away after a bad listing.

What Is Safe and Sensible

• Reading GMP as a sentiment indicator. Perfectly reasonable, and useful in combination with hard data.
• Comparing premium trends across issues. Also fine, and more informative than a single number. The GMP list shows current premiums across all live issues.
• Cross-checking with regulated data. Subscription figures on the subscription status page come from exchange feeds and carry far more weight than any dealer quote.
• Deciding on fundamentals. The prospectus, peer valuation and promoter track record are the durable inputs. See how to analyse an IPO before investing.

What to Avoid

• Entering Kostak or Subject to Sauda deals through informal intermediaries.
• Paying anyone for guaranteed allotment. Allotment in oversubscribed retail categories is a computerised lottery run by the registrar and cannot be arranged.
• Applying through multiple applications on the same PAN. This gets all your applications rejected and is a genuine regulatory violation, unlike simply reading a premium.
• Believing screenshots of premiums circulated in messaging groups. Use a tracker that aggregates multiple sources and shows a median.

The Direction of Travel

Two structural changes have reduced the grey market's importance in recent years. First, the shortened listing timeline gives far less time for a premium to build or decay. Second, richer public data, including real-time subscription and anchor allotment disclosures, gives investors regulated signals that previously only dealers had. The grey market still sets the mood, but it no longer holds an information monopoly.

Practical Position to Take

Treat GMP the way a professional treats a sentiment survey: informative, freely available, and never a substitute for the numbers in the prospectus. Combine it with the IPO calendar for timing, the performance tracker for base rates, and the listing gain calculator for scenario testing. Then decide with your own money in mind, not the crowd's.

Frequently Asked Questions

Q: Is the IPO grey market illegal in India?

A: It is unregulated rather than expressly criminalised. SEBI does not recognise, supervise or enforce grey market transactions, so they carry no legal protection.

Q: Can SEBI act against grey market activity?

A: SEBI can and does act where grey market activity involves manipulation, fraud or misleading investors, even though the market itself sits outside its formal framework.

Q: Is it legal to publish GMP data?

A: Publishing observed premiums as market information is common practice among IPO trackers and is treated as reporting, not as investment advice or an offer to transact.

Q: Can I get guaranteed IPO allotment through the grey market?

A: No. Allotment for oversubscribed retail categories is decided by a computerised lottery run by the registrar, and no intermediary can guarantee it.

Q: Should retail investors participate in grey market deals?

A: No. There is no settlement guarantee, no dispute resolution and no investor protection. Use GMP as information only.